Skip to main content

Advertisement

Table 5 Final diagnoses across the patient clusters.

From: Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data

patient clusters final diagnosis categories total
  no diagnosis benign pathologies stones and/orinflammation BPE other cancers NMI UC MI UC  
blue 16 1 6 6 0 26 2 57
red 3 0 1 1 0 5 3 13
green 14 5 6 4 2 17 1 49
purple 0 0 0 1 3 7 4 15
gold 3 0 4 0 1 7 8 23
  1. BPE, benign prostate enlargement; MI UC, muscle invasive urothelial cancer; NMI UC, non-muscle invasive urothelial cancer.